Skip to main navigation Skip to search Skip to main content

A randomized phase II study of paclitaxel with carboplatin +/- amifostine as first line treatment in advanced ovarian carcinoma.

  • FYFL de Vos
  • , AME Bos
  • , M. Schaapveld
  • , CA de Swart
  • , H. Graaf
  • , A.G. van der Zee
  • , H. M. Boezen
  • , E.G.E. de Vries
  • , P.H.B. Willemse

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)60-67
JournalGynecologic Oncology
Volume97
Issue number1
Publication statusPublished - Apr 2005

Cite this